★TPG Is Said to Pick Advisers for Asia OneHealthcare Sale or IPO
TPG exploring an exit for Asia OneHealthcare, whether via sale or IPO, signals private equity is still keen to monetize healthcare assets in a region with growing demand. This move suggests they see a strong valuation window, which could bode well for other regional healthcare plays.
The Big Market Report Take
TPG is reportedly tapping Malayan Banking and UBS to explore strategic options for its Asia OneHealthcare unit, signaling a potential sale or IPO for the Malaysian healthcare provider. This move highlights the continued private equity appetite for exiting successful healthcare investments in Southeast Asia, a region seeing robust demand for medical services and an aging population. For investors, it's a clear indicator that the M&A and IPO pipeline in Asian healthcare remains active, offering opportunities for both private and public market participation. The key thing to watch will be the valuation TPG aims for, as it will set a benchmark for similar assets in a sector that has seen significant investor interest post-pandemic.
Related Guides
Never miss a story
More from this section
- Oil Unlikely to Go Back to Pre-War Prices, Analyst Says (Video)Bloomberg Markets17m ago
- HireQuest: Not An Appealing Proposition, So I'll PassSeeking Alpha27m ago
- Iran Strategically Stronger Now Than Before WarBloomberg Markets30m ago
- Dangote Targets $40 Billion Investment in Africa Expansion DriveBloomberg Markets35m ago